Background: Preoperative portal vein embolization (PVE) is currently the standard technique used routinely to increase the size of the future remnant liver (FRL
Hepatocellular carcinoma (HCC) is the second leadingcause of cancer-related death worldwide. At firstdiagnosis, HCC is multifocal in about 35-40% of patients(1,2
Gallbladder cancer is considered a rare disease associatedwith a dismal prognosis (1-3). However, since the irruptionof laparoscopic cholecystectomy, incidental
The decline in age-adjusted mortality rates attributed tocardiovascular disease (CVD) has been characterized asthe success story of the past four decades, world